Lumativa AG, a Swiss developer of anti-infectives for women's health, has raised CHF 18 million ($16.24m) in Series A funding. Backers include Atlas Venture, BB Biotech Ventures and BioMedInvest. www.lumativa.com
Lumativa AG, a Swiss developer of anti-infectives for women's health, has raised CHF 18 million ($16.24m) in Series A funding. Backers include Atlas Venture, BB Biotech Ventures and BioMedInvest. www.lumativa.com
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.